The Dietary Components Carnosic Acid and Carnosol as Neuroprotective Agents: a Mechanistic View

Molecular Neurobiology

Volumn 53, Issue 9, 2016, Pages 6155-6168

  de Oliveira, Marcos Roberto ^a  

^a FEDERAL UNIVERSITY OF MATO GROSSO   (Brazil)

Author keywords

Brain; Carnosic acid; Carnosol; Glia; Neuron

Indexed keywords

CARNOSIC ACID; CARNOSOL; ABIETANE DERIVATIVE; NEUROPROTECTIVE AGENT;

ANTIDEPRESSANT ACTIVITY; ANTIINFLAMMATORY ACTIVITY; APOPTOSIS; BLOOD BRAIN BARRIER; CELL VIABILITY; DOWN REGULATION; EC50; ENZYME ACTIVITY; ENZYME INHIBITION; GLIA CELL; HUMAN; IN VITRO STUDY; IN VIVO STUDY; MICROGLIA; NERVE CELL; NEUROPROTECTION; NONHUMAN; PROTEIN EXPRESSION; REVIEW; SIGNAL TRANSDUCTION; UPREGULATION; ANIMAL; DIET; DRUG EFFECTS; GLIA; METABOLISM;

ANIMALS; DIET; DITERPENES, ABIETANE; HUMANS; NEUROGLIA; NEURONS; NEUROPROTECTIVE AGENTS;

EID: 84946771706     PISSN: 08937648     EISSN: 15591182     Source Type: Journal    
DOI: 10.1007/s12035-015-9519-1     Document Type: Review

References (90)

1. Birtić S, Dussort P, Pierre FX, Bily AC, Roller M (2015) Carnosic acid. Phytochemistry 115:9–19. doi:10.1016/j.phytochem.2014.12.026
2. Aruoma OI, Halliwell B, Aeschbach R, Löligers J (1992) Antioxidant and pro-oxidant properties of active rosemary constituents: carnosol and carnosic acid. Xenobiotica 22(2):257–268
3. Kuzmenko AI, Morozova RP, Nikolenko IA, Donchenko GV, Richheimer SL, Bailey DT (1999) Chemiluminescence determination of the in vivo and in vitro antioxidant activity of RoseOx and carnosic acid. J Photochem Photobiol, B 48(1):63–67. doi:10.1016/S1011-1344(99)00011-1
4. Erkan N, Ayranci G, Ayranci E (2008) Antioxidant activities of rosemary (Rosmarinus officinalis L.) extract, blackseed (Nigella sativa L.) essential oil, carnosic acid, rosmarinic acid and sesamol. Food Chem 110(1):76–82. doi:10.1016/j.foodchem.2008.01.058
5. Park JA, Kim S, Lee SY, Kim CS, Kim do K, Kim SJ, Chun HS (2008) Beneficial effects of carnosic acid on dieldrin-induced dopaminergic neuronal cell death. Neuroreport 19(13):1301–1304. doi:10.1097/WNR.0b013e32830abc1f
6. Lian KC, Chuang JJ, Hsieh CW, Wung BS, Huang GD, Jian TY, Sun YW (2010) Toxicol Appl Pharmacol 245(1):21–35. doi:10.1016/j.taap.2010.01.003
7. Mengoni ES, Vichera G, Rigano LA, Rodriguez-Puebla ML, Galliano SR, Cafferata EE, Pivetta OH, Moreno S, Vojnov AA (2011) Suppression of COX-2, IL-1β and TNF-α expression and leukocyte infiltration in inflamed skin by bioactive compounds from Rosmarinus officinalis L. Fitoterapia 82(3):414–421. doi:10.1016/j.fitote.2010.11.023
8. Yanagitai M, Itoh S, Kitagawa T, Takenouchi T, Kitani H, Satoh T (2012) Carnosic acid, a pro-electrophilic compound, inhibits LPS-induced activation of microglia. Biochem Biophys Res Commun 418(1):22–26. doi:10.1016/j.bbrc.2011.12.087
9. Satoh T, McKercher SR, Lipton SA (2013) Nrf2/ARE-mediated antioxidant actions of pro-electrophilic drugs. Free Radic Biol Med 65:645–657. doi:10.1016/j.freeradbiomed.2013.07.022
10. Pérez-Fons L, Garzón MT, Micol V (2010) Relationship between the antioxidant capacity and effect of rosemary (Rosmarinus officinalis L.) polyphenols on membrane phospholipid order. J Agric Food Chem 58(1):161–171. doi:10.1021/jf9026487
11. Maruoka H, Sasaya H, Sugihara K, Shimoke K, Ikeuchi T (2011) Low-molecular-weight compounds having neurotrophic activity in cultured PC12 cells and neurons. J Biochem 150(5):473–475. doi:10.1093/jb/mvr113
12. Wijeratne SS, Cuppett SL (2007) Potential of rosemary (Rosemarinus officinalis L.) diterpenes in preventing lipid hydroperoxide-mediated oxidative stress in Caco-2 cells. J Agric Food Chem 55(4):1193–1199. doi:10.1021/jf063089m
13. Haraguchi H, Saito T, Okamura N, Yagi A (1995) Inhibition of lipid peroxidation and superoxide generation by diterpenoids from Rosmarinus officinalis. Planta Med 61(4):333–336. doi:10.1055/s-2006-958094
14. Johnson JJ (2011) Carnosol: a promising anti-cancer and anti-inflammatory agent. Cancer Lett 305(1):1–7. doi:10.1016/j.canlet.2011.02.005
15. Visanji JM, Thompson DG, Padfield PJ (2006) Induction of G2/M phase cell cycle arrest by carnosol and carnosic acid is associated with alteration of cyclin A and cyclin B1 levels. Cancer Lett 237(1):130–136. doi:10.1016/j.canlet.2005.05.045
16. Poeckel D, Greiner C, Verhoff M, Rau O, Tausch L, Hörnig C, Steinhilber D, Schubert-Zsilavecz M, Werz O (2008) Carnosic acid and carnosol potently inhibit human 5-lipoxygenase and suppress pro-inflammatory responses of stimulated human polymorphonuclear leukocytes. Biochem Pharmacol 76(1):91–97. doi:10.1016/j.bcp.2008.04.013
17. Johnson JJ, Syed DN, Suh Y, Heren CR, Saleem M, Siddiqui IA, Mukhtar H (2010) Disruption of androgen and estrogen receptor activity in prostate cancer by a novel dietary diterpene carnosol: implications for chemoprevention. Cancer Prev Res (Phila) 3(9):1112–1123. doi:10.1158/1940-6207
18. Fawcett JR, Bordayo EZ, Jackson K, Liu H, Peterson J, Svitak A, Frey WH 2nd (2002) Inactivation of the human brain muscarinic acetylcholine receptor by oxidative damage catalyzed by a low molecular weight endogenous inhibitor from Alzheimer’s brain is prevented by pyrophosphate analogs, bioflavonoids and other antioxidants. Brain Res 950(1-2):10–20. doi:10.1016/S0006-8993(02)02981-5
19. Tamaki Y, Tabuchi T, Takahashi T, Kosaka K, Satoh T (2010) Activated glutathione metabolism participates in protective effects of carnosic acid against oxidative stress in neuronal HT22 cells. Planta Med 76(7):683–688. doi:10.1055/s-0029-1240622
20. del Baño MJ, Lorente J, Castillo J, Benavente-García O, del Río JA, Ortuño A, Quirin KW, Gerard D (2003) Phenolic diterpenes, flavones, and rosmarinic acid distribution during the development of leaves, flowers, stems, and roots of Rosmarinus officinalis. Antioxidant activity. J Agric Food Chem 51(15):4247–4253. doi:10.1021/jf0300745
21. Luis JC, Johnson CB (2005) Seasonal variations of rosmarinic and carnosic acids in rosemary extracts. Analysis of their in vitro antiradical activity. Span J Agric Res 3(1):106–112
22. Satoh T, Kosaka K, Itoh K, Kobayashi A, Yamamoto M, Shimojo Y, Kitajima C, Cui J, Kamins J, Okamoto S, Izumi M, Shirasawa T, Lipton AS (2008) Carnosic acid, a catechol-type electrophilic compound, protects neurons both in vitro and in vivo through activation of the Keap1/Nrf2 pathway via S-alkylation of targeted cysteines on Keap1. J Neurochem 104(4):1116–1131. doi:10.1111/j.1471-4159.2007.05039.x
23. Romo Vaquero M, García Villalba R, Larrosa M, Yáñez-Gascón MJ, Fromentin E, Flanagan J, Roller M, Tomás-Barberán FA, Espín JC, García-Conesa MT (2013) Bioavailability of the major bioactive diterpenoids in a rosemary extract: metabolic profile in the intestine, liver, plasma, and brain of Zucker rats. Mol Nutr Food Res 57(10):1834–1846. doi:10.1002/mnfr.201300052
24. Doolaege EH, Raes K, De Vos F, Verhé R, De Smet S (2011) Absorption, distribution and elimination of carnosic acid, a natural antioxidant from Rosmarinus officinalis, in rats. Plant Foods Hum Nutr 66(2):196–202. doi:10.1007/s11130-011-0233-5
25. Satoh T, Izumi M, Inukai Y, Tsutsumi Y, Nakayama N, Kosaka K, Shimojo Y, Kitajima C, Itoh K, Yokoi T, Shirasawa T (2008) Carnosic acid protects neuronal HT22 Cells through activation of the antioxidant-responsive element in free carboxylic acid- and catechol hydroxyl moieties-dependent manners. Neurosci Lett 434(3):260–265. doi:10.1016/j.neulet.2008.01.079
26. Talalay P (2000) Chemoprotection against cancer by induction of phase 2 enzymes. Biofactors 12(1-4):5–11
27. Itoh K, Tong KI, Yamamoto M (2004) Molecular mechanism activating Nrf2-Keap1 pathway in regulation of adaptive response to electrophiles. Free Radic Biol Med 36(10):1208–1213. doi:10.1016/j.freeradbiomed.2004.02.075
28. Padmanabhan B, Tong KI, Ohta T, Nakamura Y, Scharlock M, Ohtsuji M, Kang MI, Kobayashi A, Yokoyama S, Yamamoto M (2006) Structural basis for defects of Keap1 activity provoked by its point mutations in lung cancer. Mol Cell 21(5):689–700. doi:10.1016/j.molcel.2006.01.013
29. Kraft AD, Johnson DA, Johnson JA (2004) Nuclear factor E2-related factor 2-dependent antioxidant response element activation by tert-butylhydroquinone and sulforaphane occurring preferentially in astrocytes conditions neurons against oxidative insult. J Neurosci 24(5):1101–1112. doi:10.1523/JNEUROSCI.3817-03.2004
30. Hong F, Freeman ML, Liebler DC (2005) Identification of sensor cysteines in human Keap1 modified by the cancer chemopreventive agent sulforaphane. Chem Res Toxicol 18(12):1917–1926. doi:10.1021/tx0502138
31. Chen JH, Ou HP, Lin CY, Lin FJ, Wu CR, Chang SW, Tsai CW (2012) Carnosic acid prevents 6-hydroxydopamine-induced cell death in SH-SY5Y cells via mediation of glutathione synthesis. Chem Res Toxicol 25(9):1893–1901. doi:10.1021/tx300171u
32. Lu SC (2013) Glutathione synthesis. Biochim Biophys Acta 1830(5):3143–3153. doi:10.1016/j.bbagen.2012.09.008
33. Lu SC (2009) Regulation of glutathione synthesis. Mol Aspects Med 30(1-2):42–59. doi:10.1016/j.mam.2008.05.005
34. Lin CY, Chen JH, Fu RH, Tsai CW (2014) Induction of Pi form of glutathione S-transferase by carnosic acid is mediated through PI3K/Akt/NF-κB pathway and protects against neurotoxicity. Chem Res Toxicol 27(11):1958–1966. doi:10.1021/tx5003063
35. Salminen A, Hyttinen JM, Kaarniranta K (2011) AMP-activated protein kinase inhibits NF-κB signaling and inflammation: impact on healthspan and lifespan. J Mol Med (Berl) 89(7):667–676. doi:10.1007/s00109-011-0748-0
36. Castro-Caldas M, Carvalho AN, Rodrigues E, Henderson C, Wolf CR, Gama MJ (2012) Glutathione S-transferase pi mediates MPTP-induced c-Jun N-terminal kinase activation in the nigrostriatal pathway. Mol Neurobiol 45(3):466–477. doi:10.1007/s12035-012-8266-9
37. Carvalho AN, Marques C, Rodrigues E, Henderson CJ, Wolf CR, Pereira P, Gama MJ (2013) Ubiquitin-proteasome system impairment and MPTP-induced oxidative stress in the brain of C57BL/6 wild-type and GSTP knockout mice. Mol Neurobiol 47(2):662–672. doi:10.1007/s12035-012-8368-4
38. Hou CW, Lin YT, Chen YL, Wang YH, Chou JL, Ping LY, Jeng KC (2012) Neuroprotective effects of carnosic acid on neuronal cells under ischemic and hypoxic stress. Nutr Neurosci 15(6):257–263. doi:10.1179/1476830512Y.0000000021
39. Jiang J, Borisenko GG, Osipov A, Martin I, Chen R, Shvedova AA, Sorokin A, Tyurina YY, Potapovich A, Tyurin VA, Graham SH, Kagan VE (2004) Arachidonic acid-induced carbon-centered radicals and phospholipid peroxidation in cyclo-oxygenase-2-transfected PC12 cells. J Neurochem 90(5):1036–1049. doi:10.1111/j.1471-4159.2004.02577.x
40. Nakanishi M, Rosenberg DW (2013) Multifaceted roles of PGE2 in inflammation and cancer. Semin Immunopathol 35(2):123–137. doi:10.1007/s00281-012-0342-8
41. Trebino CE, Stock JL, Gibbons CP et al (2003) Impaired inflammatory and pain responses in mice lacking an inducible prostaglandin E synthase. Proc Natl Acad Sci U S A 100(15):9044–9049. doi:10.1073/pnas.1332766100
42. Kalinski P (2012) Regulation of immune responses by prostaglandin E2. J Immunol 188(1):21–28. doi:10.4049/jimmunol.1101029
43. Wu CR, Tsai CW, Chang SW, Lin CY, Huang LC, Tsai CW (2015) Carnosic acid protects against 6-hydroxydopamine-induced neurotoxicity in in vivo and in vitro model of Parkinson’s disease: involvement of antioxidative enzymes induction. Chem Biol Interact 225:40–46. doi:10.1016/j.cbi.2014.11.011
44. Halliwell B (2006) Oxidative stress and neurodegeneration: where are we now? J Neurochem 97(6):1634–1658. doi:10.1111/j.1471-4159.2006.03907.x
45. Itoh K, Ye P, Matsumiya T, Tanji K, Ozaki T (2015) Emerging functional cross-talk between the Keap1-Nrf2 system and mitochondria. J Clin Biochem Nutr 56(2):91–97. doi:10.3164/jcbn.14-134
46. Elomri A, Han J, Ben Abdrabbah M, Isoda H (2012) Down regulation effect of Rosmarinus officinalis polyphenols on cellular stress proteins in rat pheochromocytoma PC12 cells. Cytotechnology 64(3):231–240. doi:10.1007/s10616-011-9352-y
47. Luo W, Sun W, Taldone T, Rodina A, Chiosis G (2010) Heat shock protein 90 in neurodegenerative diseases. Mol Neurodegener 5:24. doi:10.1186/1750-1326-5-24
48. Zhao L, Rosales C, Seburn K, Ron D, Ackerman SL (2010) Alteration of the unfolded protein response modifies neurodegeneration in a mouse model of Marinesco-Sjögren syndrome. Hum Mol Genet 19(1):25–35. doi:10.1093/hmg/ddp464
49. Kimura N, Shimada N, Ishijima Y, Fukuda M, Takagi Y, Ishikawa N (2003) Nucleoside diphosphate kinases in mammalian signal transduction systems: recent development and perspective. J Bioenerg Biomembr 35(1):41–47
50. El Omri A, Han J, Yamada P, Kawada K, Ben Abdrabbah M, Isoda H (2010) Rosmarinus officinalis polyphenols activate cholinergic activities in PC12 cells through phosphorylation of ERK1/2. J Ethnopharmacol 131(2):451–458. doi:10.1016/j.jep.2010.07.006
51. Kosaka K, Mimura J, Itoh K, Satoh T, Shimojo Y, Kitajima C, Maruyama A, Yamamoto M, Shirasawa T (2010) Role of Nrf2 and p62/ZIP in the neurite outgrowth by carnosic acid in PC12h cells
52. Vaka SR, Murthy SN, Repka MA, Nagy T (2011) Upregulation of endogenous neurotrophin levels in the brain by intranasal administration of carnosic acid. J Pharm Sci 100(8):3139–3145. doi:10.1002/jps.22528
53. Davis JB (1996) Oxidative mechanisms in beta-amyloid cytotoxicity. Neurodegeneration 5(4):441–444
54. Markesbery WR (1997) Oxidative stress hypothesis in Alzheimer’s disease. Free Radic Biol Med 23(1):134–147. doi:10.1016/S0891-5849(96)00629-6
55. Gupta A, Iadecola C (2015) Impaired Aβ clearance: a potential link between atherosclerosis and Alzheimer’s disease. Front Aging Neurosci 7:115. doi:10.3389/fnagi.2015.00115
56. Salminen A, Haapasalo A, Kauppinen A, Kaarniranta K, Soininen H, Hiltunen M (2015) Impaired mitochondrial energy metabolism in Alzheimer’s disease: Impact on pathogenesis via disturbed epigenetic regulation of chromatin landscape. Prog Neurobiol 131:1–20. doi:10.1016/j.pneurobio.2015.05.001
57. Meng P, Yoshida H, Matsumiya T (2013) Carnosic acid suppresses the production of amyloid-β 1-42 by inducing the metalloprotease gene TACE/ADAM17 in SH-SY5Y human neuroblastoma cells. Neurosci Res 75(2):94–102. doi:10.1016/j.neures.2012.11.007
58. Martin D, Rojo AI, Salinas M, Diaz R, Gallardo G, Alam J, De Galarreta CM, Cuadrado A (2004) Regulation of heme oxygenase-1 expression through the phosphatidylinositol 3-kinase/Akt pathway and the Nrf2 transcription factor in response to the antioxidant phytochemical carnosol. J Biol Chem 279(10):8919–8929. doi:10.1074/jbc.M309660200
59. Kosaka K, Yokoi T (2003) Carnosic acid, a component of rosemary (Rosmarinus officinalis L.), promotes synthesis of nerve growth factor in T98G human glioblastoma cells. Biol Pharm Bull 26(11):1620–1622. doi:10.1248/bpb.26.1620
60. Mimura J, Kosaka K, Maruyama A, Satoh T, Harada N, Yoshida H, Satoh K, Yamamoto M, Itoh K (2011) Nrf2 regulates NGF mRNA induction by carnosic acid in T98G glioblastoma cells and normal human astrocytes. J Biochem 150(2):209–217. doi:10.1093/jb/mvr065
61. Vigé X, Costa E, Wise BC (1991) Mechanism of nerve growth factor mRNA regulation by interleukin-1 and basic fibroblast growth factor in primary cultures of rat astrocytes. Mol Pharmacol 40(2):186–192
62. Friedman WJ, Thakur S, Seidman L, Rabson AB (1996) Regulation of nerve growth factor mRNA by interleukin-1 in rat hippocampal astrocytes is mediated by NFkappaB. J Biol Chem 271(49):31115–31120. doi:10.1074/jbc.271.49.31115
63. Galve-Roperh I, Malpartida JM, Haro A, Brachet P, Díaz-Laviada I (1997) Regulation of nerve growth factor secretion and mRNA expression by bacterial lipopolysaccharide in primary cultures of rat astrocytes. J Neurosci Res 49(5):569–575
64. Sofroniew MV, Howe CL, Mobley WC (2001) Nerve growth factor signaling, neuroprotection, and neural repair. Annu Rev Neurosci 24:1217–1281. doi:10.1146/annurev.neuro.24.1.1217
65. Maes M, Fišar Z, Medina M, Scapagnini G, Nowak G, Berk M (2012) New drug targets in depression: inflammatory, cell-mediated immune, oxidative and nitrosative stress, mitochondrial, antioxidant, and neuroprogressive pathways. And new drug candidates—Nrf2 activators and GSK-3 inhibitors. Inflammopharmacology 20(3):127–150. doi:10.1007/s10787-011-0111-7
66. Martín-de-Saavedra MD, Budni J, Cunha MP et al (2013) Nrf2 participates in depressive disorders through an anti-inflammatory mechanism. Psychoneuroendocrinology 38(10):2010–2022. doi:10.1016/j.psyneuen.2013.03.020
67. Bakunina N, Pariante CM, Zunszain PA (2015) Immune mechanisms linked to depression via oxidative stress and neuroprogression. Immunology 144(3):365–373. doi:10.1111/imm.12443
68. Yoshida H, Mimura J, Imaizumi T, Matsumiya T, Ishikawa A, Metoki N, Tanji K, Ota K, Hayakari R, Kosaka K, Itoh K, Satoh K (2011) Edaravone and carnosic acid synergistically enhance the expression of nerve growth factor in human astrocytes under hypoxia/reoxygenation. Neurosci Res 69(4):291–298. doi:10.1016/j.neures.2010.12.016
69. Yoshida H, Yanai H, Namiki Y, Fukatsu-Sasaki K, Furutani N, Tada N (2006) Neuroprotective effects of edaravone: a novel free radical scavenger in cerebrovascular injury. CNS Drug Rev 12(1):9–20. doi:10.1111/j.1527-3458.2006.00009.x
70. Higashi Y (2009) Edaravone for the treatment of acute cerebral infarction: role of endothelium-derived nitric oxide and oxidative stress. Expert Opin Pharmacother 10(2):323–331. doi:10.1517/14656560802636888
71. Mattson MP, Cheng A (2006) Neurohormetic phytochemicals: low-dose toxins that induce adaptive neuronal stress responses. Trends Neurosci 29(11):632–639. doi:10.1016/j.tins.2006.09.001
72. Foresti R, Bains SK, Pitchumony TS, de Castro Brás LE, Drago F, Dubois-Randé JL, Bucolo C, Motterlini R (2013) Small molecule activators of the Nrf2-HO-1 antioxidant axis modulate heme metabolism and inflammation in BV2 microglia cells. Pharmacol Res 76:132–148. doi:10.1016/j.phrs.2013.07.010
73. Sperner-Unterweger B, Kohl C, Fuchs D (2014) Immune changes and neurotransmitters: possible interactions in depression? Prog Neuropsychopharmacol Biol Psychiatry 48:268–276. doi:10.1016/j.pnpbp.2012.10.006
74. Cederbaum AI, Lu Y, Wang X, Wu D (2015) Synergistic toxic interactions between CYP2E1, LPS/TNFα, and JNK/p38 MAP kinase and their implications in alcohol-induced liver injury. Adv Exp Med Biol 815:145–172. doi:10.1007/978-3-319-09614-8_9
75. Yoshida H, Meng P, Matsumiya T et al (2014) Carnosic acid suppresses the production of amyloid-β 1-42 and 1-43 by inducing an α-secretase TACE/ADAM17 in U373MG human astrocytoma cells. Neurosci Res 79:83–93. doi:10.1016/j.neures.2013.11.004
76. Mangoura D, Sakellaridis N, Jones J, Vernadakis A (1989) Early and late passage C-6 glial cell growth: similarities with primary glial cells in culture. Neurochem Res 14(10):941–947
77. Kim SY, Park E, Park JA et al (2010) The plant phenolic diterpene carnosol suppresses sodium nitroprusside-induced toxicity in c6 glial cells. J Agric Food Chem 58(3):1543–1550. doi:10.1021/jf903294x
78. Vincent VA, Tilders FJ, Van Dam AM (1998) Production, regulation and role of nitric oxide in glial cells. Mediators Inflamm 7(4):239–255. doi:10.1080/09629359890929
79. Barres BA, Barde Y (2000) Neuronal and glial cell biology. Curr Opin Neurobiol 10(5):642–648. doi:10.1016/S0959-4388(00)00134-3
80. Jaronczyk K, Bui L, Soong JM, McLaughlin BE, Marks GS, Brien JF, Nakatsu K (2004) The source of heme for vascular heme oxygenase II: de novo heme biosynthesis in rat aorta. Can J Physiol Pharmacol 82(4):218–224
81. Wegiel B, Otterbein LE (2012) Go green: the anti-inflammatory effects of biliverdin reductase. Front Pharmacol 3:47. doi:10.3389/fphar.2012.00047
82. Cheng L, Li F, Ma R, Hu X (2015) Forsythiaside inhibits cigarette smoke-induced lung inflammation by activation of Nrf2 and inhibition of NF-κB. Int Immunopharmacol 28(1):494–499. doi:10.1016/j.intimp.2015.07.011
83. Choudhury S, Ghosh S, Gupta P, Mukherjee S, Chattopadhyay S (2015) Inflammation-induced ROS generation causes pancreatic cell death through modulation of Nrf2-NF-κB and SAPK/JNK pathway. Free Radic Res 20:1–41. doi:10.3109/10715762.2015.1075016
84. Jarrott B, Williams SJ (2015) Chronic brain inflammation: the neurochemical basis for drugs to reduce inflammation. Neurochem Res. doi:10.1007/s11064-015-1661-7
85. Azad N, Rasoolijazi H, Joghataie MT, Soleimani S (2011) Neuroprotective effects of carnosic acid in an experimental model of Alzheimer’s disease in rats. Cell J 13(1):39–44
86. Machado DG, Bettio LE, Cunha MP, Capra JC, Dalmarco JB, Pizzolatti MG, Rodrigues AL (2009) Antidepressant-like effect of the extract of Rosmarinus officinalis in mice: involvement of the monoaminergic system. Prog Neuropsychopharmacol Biol Psychiatry 33(4):642–650. doi:10.1016/j.pnpbp.2009.03.004
87. Machado DG, Cunha MP, Neis VB et al (2013) Antidepressant-like effects of fractions, essential oil, carnosol and betulinic acid isolated from Rosmarinus officinalis L. Food Chem 136(2):999–1005. doi:10.1016/j.foodchem.2012.09.028
88. Machado DG, Cunha MP, Neis VB et al (2012) Rosmarinus officinalis L. hydroalcoholic extract, similar to fluoxetine, reverses depressive-like behavior without altering learning deficit in olfactory bulbectomized mice. J Ethnopharmacol 143(1):158–169. doi:10.1016/j.jep.2012.06.017
89. Chen Y, Wang H, Zhang R, Wang H, Peng Z, Sun R, Tan Q (2012) Microinjection of sanguinarine into the ventrolateral orbital cortex inhibits Mkp-1 and exerts an antidepressant-like effect in rats. Neurosci Lett 506(2):327–331. doi:10.1016/j.neulet.2011.11.038
90. Zanella CA, Treichel H, Cansian RL, Roman SS (2012) The effects of acute administration of the hydroalcoholic extract of rosemary (Rosmarinus officinalis L.) (Lamiaceae) in animal models of memory. Braz J Pharm Sci 48(3):389–397. doi:10.1590/S1984-82502012000300005